Home
  >  
Section 42
  >  
Chapter 41,373

Single apomorphine pretreatment results in a rapid decline in high-affinity dopamine binding to the striatal dopamine D-2 receptor

Severson, J.A.; Randall, P.K.; Wilcox, R.E.

European Journal of Pharmacology 188(4-5): 283-286

1990

ISSN/ISBN: 0014-2999
PMID: 2114303
DOI: 10.1016/0922-4106(90)90013-n
Accession: 041372392
Download citation:  
Text
  |  
BibTeX
  |  
RIS
The formation of a ternary complex of agonist, receptor, and G-protein precedes inhibition of adenylate cyclase and is associated with high-affinity agonist binding. The present experiment was conducted to determine if a single direct dopamine (DA) agonist, apomorphine (APO), pretreatment could produce a rapid uncoupling of the striatal DA D-2 receptor from its G-proteins. APO (30 mg/kg, i.p.) and saline were administered once, with killing 60 or 90 min following the APO or vehicle treatment. APO pretreatment resulted in a reduction in the high-affinity binding of DA to the striatal DA D-2 receptor without altering total agonist binding. The total density of antagonist-defined D-2 receptors (Bmax) was not altered by the treatment. The present results represent, to our knowledge, the first demonstration of changes in high-affinity agonist binding to the DA D-2 receptor following a single in vivo pretreatment of a direct DA agonist.

PDF emailed within 0-6 h: $19.90




Related References

Riffee, W.H.; Wilcox, R.E.; Vaughn, D.M.; Smith, R.V. 1982: Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine Psychopharmacology 77(2): 146-149
Kessler, R.M.; Ansari, M.S.; Schmidt, D.E.; de Paulis, T.; Clanton, J.A.; Innis, R.; al-Tikriti, M.; Manning, R.G.; Gillespie, D. 1991: High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors Life Sciences 49(8): 617-628
Kessler, R.M.; Sib Ansari, M.; Schmidt, D.E.; De Paulis, T.; Clanton, J.A.; Mohammed, A.L.T.I.K.R.I.T.I.; Manning, R.G.; Gillespie, D. 1991: High affinity dopamine D2 receptor radioligands. II : [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors Life Sciences (1973) 49(8): 617-628
Kessler, R.M.; Ansari, M.Sib; Schmidt, D.E. 1991: High affinity dopamine D2 receptor radioligands. 2. (125I)epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors Life Sciences 49(8 ): 7-28
Dalton, V.S.; Zavitsanou, K. 2011: Rapid changes in d1 and d2 dopamine receptor binding in striatal subregions after a single dose of phencyclidine Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology 9(2): 67-72
Bloemen, O.J.N.; de Koning, M.B.; Gleich, T.; Meijer, J.; de Haan, L.; Linszen, D.H.; Booij, J.; van Amelsvoort, T.ér.ès.A.M.J. 2013: Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 23(2): 126-132
Seiler, M.P.; Markstein, R. 1982: Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding Molecular Pharmacology 22(2): 281-289
Gatley, S.J.; Gifford, A.N.; Carroll, F.I.; Volkow, N.D. 2000: Sensitivity of binding of high-affinity dopamine receptor radioligands to increased synaptic dopamine Synapse 38(4): 483-488
MacRae, P.G.; Spirduso, W.W.; Walters, T.J.; Farrar, R.P.; Wilcox, R.E. 1987: Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolites in presenescent older rats Psychopharmacology 92(2): 236-240
MacRae, P.G.; Spirduso, W.W.; Cartee, G.D.; Farrar, R.P.; Wilcox, R.E. 1987: Endurance training effects on striatal D2 dopamine receptor binding and striatal dopamine metabolite levels Neuroscience Letters 79(1-2): 138-144
Di Chiara, G.; Porceddu, M.L.; Spano, P.F.; Gessa, G.L. 1977: Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid Brain Research 130(2): 374-382
Weihmuller, F.B.; O'dell, S.J.; Marshall, J.F. 1993: L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection Brain Research 623(2): 303-307
Werle, E.; Lenz, T.; Strobel, G.; Weicker, H. 1988: 3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes Naunyn-Schmiedeberg's Archives of Pharmacology 338(1): 28-34
Zaworski, P.G.; Evans, D.L.; Figur, L.; Adams, E.; Slightom, J.; Merchant, K.; Gill, G.S. 1995: A point mutation resulting in a SER fwdarw PRO change in the third extracellular domaine of the human dopamine D3 receptor abolishes high affinity dopamine binding Society for Neuroscience Abstracts 21(1-3): 624
Lévesque, D.; Di Paolo, T. 1988: Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol Neuroscience Letters 88(1): 113-118
Kuczenski, R.; Leith, N.J.; Applegate, C.D. 1983: Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment Brain Research 258(2): 333-337
Leff, S.E.; Creese, I. 1985: Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor Molecular Pharmacology 27(2): 184-192
Durdagi, S.; Salmas, R.E.; Stein, M.; Yurtsever, M.; Seeman, P. 2016: Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques Acs Chemical Neuroscience 7(2): 185-195
Wai, J.M.; Grassetti, A.; Slifstein, M.; Matuskey, D.; Nabulsi, N.; Ropchan, J.; Labaree, D.; Huang, Y.; Martinez, D. 2019: Binge alcohol use is not associated with alterations in striatal dopamine receptor binding or dopamine release Drug and Alcohol Dependence 205: 107627
Severson, J.A. 1984: High affinity agonist binding to striatal d 2 dopamine receptors in aged mouse Society for Neuroscience Abstracts 10(1): 445